Mc Elhenny Sheffield Capital Management, LLC Bristol Myers Squibb CO Transaction History

Mc Elhenny Sheffield Capital Management, LLC

$289 Million
Q2 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$65.71 - $74.53 $60,387 - $68,493	919 Added 40.9%	3,166 $219,000
Q4 2022 Jan 11, 2023	BUY	$68.48 - $81.09 $153,874 - $182,209	2,247 New	2,247 $0
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $187,432 - $206,428	2,581 Added 18.33%	16,659 $1.28 Million
Q1 2022 Apr 20, 2022	SELL	$61.48 - $73.72 $31,354 - $37,597	-510 Reduced 3.5%	14,078 $1.03 Million
Q4 2021 Jan 12, 2022	BUY	$53.63 - $62.52 $101,146 - $117,912	1,886 Added 14.85%	14,588 $910,000
Q3 2021 Oct 12, 2021	BUY	$59.17 - $69.31 $751,577 - $880,375	12,702 New	12,702 $752,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Elhenny Sheffield Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Elhenny Sheffield Capital Management, LLC with notifications on news.

Account